San Diego, CA and Boston, MA - October 20th, 2020 - Scientist.com, the healthcare industry’s leading marketplace for life science research, today announced a strategic partnership with Clora, the best place to discover, build and manage on-demand life science teams. Marketplace users now have access to over 6,000 registered life science experts within Clora’s global network that spans all areas of therapeutic discovery and development.
"By providing on-demand access to a diverse pool of research experts, Clora helps keep time-critical R&D projects on track, avoiding costly delays, failures, and blown budgets," said Kevin Lustig, Ph.D., Scientist.com’s Founder and CEO. “Together we offer life science researchers a one-stop shop in which they can outsource everything but the genius.”
Clora has cracked the code on how to make on-demand team building a painless experience for both the life science experts and the companies they connect with through Clora’s marketplace. By harnessing the power of data to find specialized industry expertise and meet specific research needs, Clora is able to fill talent gaps within days instead of weeks or months.
"By connecting researchers at many of the world’s top pharmaceutical and biotechnology companies with thousands of global research suppliers, Scientist.com has made it easy to outsource laboratory services,” said Rahul Chaturvedi, Clora’s Founder and CEO. “Working together, Scientist.com and Clora can accelerate the entire R&D process and reshape the future of life science research.”
Scientist.com is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saves time and money, reduces risk, and provides access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, over 80 biotechnology companies, the Biotechnology Innovation Organization (BIO), and the US National Institutes of Health (NIH).
Clora is based in Boston, MA, and was built by industry and technology veterans who collectively have experienced the pain and costs associated with delays in the development of new therapies. Clora believes that the future of work in the life sciences will be achieved through software ensuring access to the right talent at the right time.
Clora’s investors include Spark Capital, Felicis Ventures, iSeed Ventures, Ludlow Ventures, Notation Capital, and Social Capital among others.